|
.
NPI Detail
NPI: 1548202641
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
330 XXXXXXXXX XXX
ST 207 BOSTON, MA 022155400
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1548202641*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
Procedure | Description | Number Submitted | Medicare Payment |
36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX
|
82565
|
ASSAY OF CREATININE
|
XXXXX
|
$XXXXX.XX
|
84520
|
ASSAY OF UREA NITROGEN
|
XXXXX
|
$XXXXX.XX
|
84460
|
ALANINE AMINO (ALT) (SGPT)
|
XXXXX
|
$XXXXX.XX
|
84450
|
TRANSFERASE (AST) (SGOT)
|
XXXXX
|
$XXXXX.XX
|
80051
|
ELECTROLYTE PANEL
|
XXXXX
|
$XXXXX.XX
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
Procedure | Description | Number Submitted | Medicare Payment |
J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
J1453
|
Fosaprepitant injection
|
XXXXXX
|
$XXXXX.XX
|
J0585
|
Injection,onabotulinumtoxina
|
XXXXXX
|
$XXXXXX.XX
|
J9263
|
Oxaliplatin
|
XXXXXX
|
-
|
J3380
|
Injection, vedolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
J9144
|
Daratumumab, hyaluronidase
|
XXXXXX
|
$XXXXXXX.XX
|
J0485
|
Belatacept injection
|
XXXXX
|
$XXXXXX.XX
|
J1569
|
Gammagard liquid injection
|
XXXXX
|
$XXXXXXX.XX
|
J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXXX.XX
|
J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
J2323
|
Natalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
J3111
|
Inj. romosozumab-aqqg 1 mg
|
XXXXX
|
$XXXXXX.XX
|
J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
J0256
|
Alpha 1 proteinase inhibitor
|
XXXXX
|
$XXXXXX.XX
|
J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
J1642
|
Inj heparin sodium per 10 u
|
XXXXX
|
-
|
J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
J3262
|
Tocilizumab injection
|
XXXXX
|
$XXXXXX.XX
|
J0878
|
Daptomycin injection
|
XXXXX
|
-
|
J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
J9312
|
Inj., rituximab, 10 mg
|
XXXXX
|
$XXXXXXX.XX
|
J2315
|
Naltrexone, depot form
|
XXXXX
|
$XXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
Procedure | Description | Number Submitted | Medicare Payment |
G0463
|
Hospital outpt clinic visit
|
XXXXXX
|
$XXXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|